Getting patented meds on NLEM list an uphill battle says committee member
15 Sep 2022 //
ECONOMIC TIMES
Diabetes, patented TB, HIV drugs enter essential list
13 Sep 2022 //
ECONOMICTIMES
Otsuka Announces Approval in EU of Pediatric, 25 mg Dispersible-Tablet
06 Oct 2021 //
JIHO
Deltyba® (delamanid) approved in Russian Federation for treatment of pulmonary
25 May 2020 //
PRESS RELEASE
Delamanid, Bedaquiline-based therapy to be boosted to tackle MDR TB
08 Feb 2019 //
PHARMA BIZ
Johnson and Johnson asked to cut down price of new TB drug
23 Oct 2018 //
ECONOMIC TIMES
J&J, Macleods in talks for licence deal of tuberculosis drug
12 Mar 2018 //
ECONOMIC TIMES
WHO invites applications from drug companies pre-qualification of MDR TB drugs
09 Mar 2018 //
ECONOMIC TIMES